1 Min Read
Feb 15 (Reuters) - Bioinvent
* Q4 net sales amounted to sek 31 (10) million.
* Q4 profit/loss after tax: sek -7.3 (-21) million Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.